Diagnostic Imaging Market - Global Forecast To 2030
商品番号 : SMB-43038
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年9月 |
| ページ数 | 394 |
| 図表数 | 454 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、画像診断市場をモダリティ、アプリケーション、エンドユーザー、地域の観点から分析しています。市場の成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダーの競争環境の詳細を提供しています。さらに、本レポートでは、マイクロマーケットの成長傾向を分析し、主要5地域および対応する国における業界収益を予測しています。
本レポートは、画像診断市場全体とそのサブセグメントの収益数値に関する近似値を提供することで、市場リーダー企業と新規参入企業にとって役立ちます。また、ステークホルダーが競争環境を理解し、自社のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。さらに、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供するのにも役立ちます。
世界の画像診断市場は、2025年の265億1,000万米ドルから2030年には329億米ドルに達すると予測されており、2025年から2030年にかけて年平均成長率(CAGR)は4.4%です。市場は非侵襲的技術の利用増加により成長しています。画像診断市場の拡大は、政府の取り組みの強化、臨床試験、そして研究開発への重点的な取り組みにも関連しています。
The global diagnostic imaging market is projected to reach USD 32.90 billion by 2030 from USD 26.51 billion in 2025, at a CAGR of 4.4% from 2025 to 2030. The market is growing due to the increased use of non-invasive technology. The expansion of the diagnostic imaging market is also linked to heightened government initiatives, clinical trials, and a strong emphasis on research and development.

“The ultrasound systems segment held the largest share of the market in 2024.”
Based on modality, the diagnostic imaging market is segmented into CT scanners, MRI systems, ultrasound systems, X-ray imaging systems, nuclear imaging systems, and mammography systems. The ultrasound systems segment held the largest market share in 2024. Advancements in 3D and 4D imaging, along with AI features and improved portability, are enhancing the use of ultrasound in point-of-care and emergency settings, making it even more accessible. The rising prevalence of chronic diseases and the increasing demand for early and accurate diagnoses are solidifying the dominance of ultrasound systems in the market.
“The radiology/general imaging applications segment held the largest share of the ultrasound systems market during the forecast period.”
The ultrasound systems market is segmented by applications: radiology/general imaging, cardiology, obstetrics/gynecology, vascular applications, urology, and other applications. From 2025 to 2030, the radiology/general imaging application segment held the largest share of the market. Demand in this market is driven by the increasing use of point-of-care ultrasonography (POCUS) among internal medicine, emergency departments, and general practitioners.

“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
The diagnostic imaging market in the APAC region is projected to register the highest CAGR during the forecast period. This growth is primarily driven by the evolving healthcare infrastructure and the increasing focus of major players in the region.
Hospitals and diagnostic facilities are making significant investments in modern imaging equipment, particularly in rapidly developing countries like China and India. These factors are expected to contribute to the expansion of the diagnostic imaging market in this area.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
- By Designation: D-level Executives (14%), C-level Executives (10%), and Others (76%)
- By Region: North America (40%), Europe (32%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (3%)
The prominent players in the diagnostic imaging market are Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), and FUJIFILM Corporation (Japan), among others.

Research Coverage
This report studies the diagnostic imaging market based on modality, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their growth trends and forecasts the revenue of the industry for five leading geographies, along with corresponding countries
Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall diagnostic imaging market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
- Analysis of key drivers (growing geriatric population and subsequent rise in chronic diseases, increasing demand for early diagnosis across clinical applications, technological advancements in diagnostic imaging modalities, and increasing funding and investments by public-private organizations), restraints (high cost of diagnostic imaging systems, technological limitations associated with standalone systems, unfavorable reimbursement scenario, and inadequate supply of helium), opportunities (emerging economies offer high growth potential, increasing establishment of hospitals and diagnostic imaging centers, adoption of AI and analytics in diagnostic imaging, growing adoption of teleradiology, and contract-based radiology solutions and mobile solutions), and challenges (hospital budget cuts, increasing adoption of refurbished diagnostic imaging systems, and shortage of trained professionals) influencing the growth of the diagnostic imaging market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the diagnostic imaging market
- Market Development: Comprehensive information about lucrative markets. The report analyzes the diagnostic imaging market across varied regions
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the diagnostic imaging market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like GE HealthCare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), and FUJIFILM Corporation (Japan).
Table of Contents
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 STUDY SCOPE 33
1.3.1 MARKETS CONSIDERED AND REGIONS COVERED 33
1.3.2 INCLUSIONS AND EXCLUSIONS 34
1.4 YEARS CONSIDERED 34
1.5 CURRENCY CONSIDERED 35
1.6 STAKEHOLDERS 35
1.7 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
2.1.1 SECONDARY RESEARCH 38
2.1.2 PRIMARY RESEARCH 39
2.1.2.1 Primary sources 39
2.1.2.2 Key industry insights 40
2.1.2.3 Breakdown of primaries 40
2.2 MARKET SIZE ESTIMATION 41
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION 43
2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 44
2.2.3 GROWTH FORECAST 45
2.2.4 CAGR PROJECTIONS 45
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION APPROACH 46
2.4 MARKET SHARE ESTIMATION 47
2.5 RESEARCH ASSUMPTIONS 47
2.6 RISK ASSESSMENT 48
2.7 GROWTH RATE ASSUMPTIONS 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 52
4.1 DIAGNOSTIC IMAGING MARKET OVERVIEW 52
4.2 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY REGION AND END USER, 2025 53
4.3 REGIONAL SNAPSHOT OF DIAGNOSTIC IMAGING MARKET 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
5.2.1 DRIVERS 56
5.2.1.1 Growing geriatric population and the rising prevalence of associated diseases 56
5.2.1.2 Increasing demand for early diagnosis and widening scope of clinical applications 57
5.2.1.3 Technological advancements in diagnostic imaging modalities 57
5.2.1.4 Increasing investments, funds, and grants by public-private organizations 58
5.2.2 RESTRAINTS 59
5.2.2.1 High cost of diagnostic imaging systems 59
5.2.2.2 Technological limitations associated with standalone systems 60
5.2.2.3 Unfavorable reimbursement scenario 60
5.2.2.4 Shortage of helium 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Emerging economies offer high growth potential 61
5.2.3.2 Adoption of AI and analytics in diagnostic imaging 61
5.2.3.3 Increasing establishment of hospitals and diagnostic imaging centers 62
5.2.3.4 Increasing adoption of teleradiology 63
5.2.3.5 Contract-based radiology solutions and mobile solutions 64
5.2.4 CHALLENGES 64
5.2.4.1 Hospital budget cuts 64
5.2.4.2 Increasing adoption of refurbished diagnostic imaging systems 64
5.2.4.3 Dearth of trained professionals 65
5.3 PRICING ANALYSIS 65
5.4 VALUE CHAIN ANALYSIS 67
5.4.1 RESEARCH & DEVELOPMENT 67
5.4.2 MANUFACTURING & ASSEMBLY 67
5.4.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALE SERVICES 67
5.5 ECOSYSTEM ANALYSIS 68
5.6 SUPPLY CHAIN ANALYSIS 68
5.6.1 PROMINENT COMPANIES 68
5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES 68
5.6.3 END USERS 68
5.7 PORTER’S FIVE FORCES ANALYSIS 69
5.7.1 BARGAINING POWER OF BUYERS 69
5.7.2 BARGAINING POWER OF SUPPLIERS 70
5.7.3 THREAT OF NEW ENTRANTS 70
5.7.4 THREAT OF SUBSTITUTES 70
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 70
5.8 REGULATORY LANDSCAPE 70
5.8.1 NORTH AMERICA 70
5.8.1.1 US 70
5.8.1.2 Canada 71
5.8.2 EUROPE 72
5.8.3 ASIA PACIFIC 73
5.8.3.1 Japan 73
5.8.3.2 China 73
5.8.3.3 India 75
5.9 TRENDS IMPACTING CUSTOMER BUSINESS 75
5.9.1 INCREASING ADOPTION OF HYBRID DIAGNOSTIC IMAGING MODALITIES 75
5.10 TECHNOLOGY ANALYSIS 76
5.10.1 KEY TECHNOLOGIES 76
5.10.1.1 Magnetic resonance imaging (MRI) 76
5.10.1.2 Computed tomography (CT) 77
5.10.1.3 Ultrasound imaging 77
5.10.2 COMPLEMENTARY TECHNOLOGIES 77
5.10.2.1 Picture archiving and communication systems (PACS) 77
5.10.2.2 Artificial intelligence (AI) for image analysis 78
5.10.2.3 Radiology information systems (RIS) 78
5.10.3 ADJACENT TECHNOLOGIES 78
5.10.3.1 Digital pathology 78
5.10.3.2 Molecular imaging/PET-CT 79
5.10.3.3 Wearable imaging sensors 79
5.11 REIMBURSEMENT SCENARIO 79
5.12 TRADE ANALYSIS 86
5.12.1 IMPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2020─2024 (USD THOUSAND) 87
5.12.2 EXPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2020─2024 (USD THOUSAND) 88
5.12.3 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS 89
5.12.3.1 Import data for ultrasound systems, by country,
2020─2024 (USD Thousand) 89
5.12.3.2 Export data for ultrasound systems, by country,
2020─2024 (USD Thousand) 90
5.12.4 TRADE ANALYSIS FOR MAGNETIC RESONANCE IMAGING SYSTEMS 91
5.12.4.1 Import data for magnetic resonance imaging systems, by country, 2020─2024 (USD Thousand) 91
5.12.4.2 Export data for magnetic resonance imaging systems, by country, 2020─2024 (USD Thousand) 92
5.12.5 TRADE ANALYSIS FOR X-RAY SYSTEMS 93
5.12.5.1 Import data for X-ray systems, by country,
2020─2024 (USD Thousand) 93
5.12.5.2 Export data for X-ray systems, by country,
2020─2024 (USD Thousand) 94
5.13 PATENT ANALYSIS 95
5.14 CASE STUDY ANALYSIS 101
5.15 KEY CONFERENCES AND EVENTS (2025–2026) 102
5.16 UNMET NEEDS 103
5.17 IMPACT OF AI ON DIAGNOSTIC IMAGING MARKET 103
5.17.1 INTRODUCTION 103
5.17.2 MARKET POTENTIAL OF AI IN DIAGNOSTIC IMAGING 103
5.17.3 AI USE CASES 104
5.17.4 KEY COMPANIES IMPLEMENTING AI 104
5.17.5 FUTURE OF GENERATIVE AI IN DIAGNOSTIC IMAGING 104
5.18 IMPACT OF 2025 US TARIFF 104
5.18.1 INTRODUCTION 104
5.18.2 KEY TARIFF RATES 105
5.18.3 PRICE IMPACT ANALYSIS 105
5.18.4 IMPACT ON COUNTRY/REGION 105
5.18.4.1 United States 105
5.18.4.2 Europe 106
5.18.4.3 Asia Pacific 106
5.18.5 IMPACT ON END-USE INDUSTRIES 106
6 DIAGNOSTIC IMAGING MARKET, BY APPLICATION 107
6.1 INTRODUCTION 108
6.2 X-RAY IMAGING SYSTEMS 108
6.2.1 GENERAL RADIOGRAPHY 108
6.2.1.1 Wide-scale application in chest imaging to drive market 108
6.2.2 DENTISTRY 109
6.2.2.1 High prevalence of dental disorders to drive market 109
6.2.3 FLUOROSCOPY 109
6.2.3.1 Rising use in gastrointestinal imaging to support market growth 109
6.3 MRI SYSTEMS 110
6.3.1 BRAIN & NEUROLOGICAL MRI 111
6.3.1.1 Rising incidence of neurodegenerative diseases to drive market 111
6.3.2 SPINE & MUSCULOSKELETAL MRI 112
6.3.2.1 Ability to diagnose musculoskeletal disorders to drive market 112
6.3.3 VASCULAR MRI 112
6.3.3.1 Adoption of AI to support market growth 112
6.3.4 PELVIC & ABDOMINAL MRI 113
6.3.4.1 Ability to detect prostate and cervical cancer to propel market 113
6.3.5 BREAST MRI 113
6.3.5.1 Growing awareness about early breast cancer screening
to drive market 113
6.3.6 CARDIAC MRI 114
6.3.6.1 Rising incidence of CVD to support market growth 114
6.4 ULTRASOUND SYSTEMS 114
6.4.1 RADIOLOGY/GENERAL IMAGING 115
6.4.1.1 Extensive use in image-guided radiotherapy and
radiology ultrasound to drive market 115
6.4.2 OBSTETRICS/GYNECOLOGY 116
6.4.2.1 Advancements in AI models for image guidance to
support market growth 116
6.4.3 CARDIOLOGY 117
6.4.3.1 Rising prevalence of cardiovascular diseases to drive market 117
6.4.4 VASCULAR 117
6.4.4.1 Identification of vessel blockages and blot clots for early disease diagnosis to support market growth 117
6.4.5 UROLOGY 118
6.4.5.1 Growing awareness about therapeutic benefits of urological ultrasound to propel market 118
6.4.6 OTHER APPLICATIONS 118
6.5 CT SCANNERS 119
6.5.1 CARDIOLOGY 120
6.5.1.1 Rising incidence of obesity and hypertension to propel market 120
6.5.2 ONCOLOGY 120
6.5.2.1 Rising burden of cancer to drive market 120
6.5.3 NEUROLOGY 121
6.5.3.1 Increasing incidence of dementia and Alzheimer’s to fuel market 121
6.5.4 OTHER APPLICATIONS 122
6.6 NUCLEAR IMAGING SYSTEMS 122
6.6.1 ONCOLOGY 123
6.6.1.1 Ability to distinguish between benign and malignant tumors to drive market 123
6.6.2 CARDIOLOGY 123
6.6.2.1 Rising incidence of coronary heart disease to support market 123
6.6.3 NEUROLOGY 124
6.6.3.1 Rising use of SPECT and PET systems for brain perfusion imaging to drive market 124
6.6.4 OTHER APPLICATIONS 125
6.7 MAMMOGRAPHY SYSTEMS 125
6.7.1 TECHNOLOGICAL ADVANCEMENTS IN MAMMOGRAPHY SYSTEMS TO SUPPORT MARKET GROWTH 125
7 DIAGNOSTIC IMAGING MARKET, BY MODALITY 127
7.1 INTRODUCTION 128
7.2 CT SCANNERS 128
7.2.1 CONVENTIONAL CT SCANNERS 129
7.2.1.1 High-slice CT scanners 130
7.2.1.1.1 High image resolution to drive market 130
7.2.1.2 Mid-slice CT scanners 131
7.2.1.2.1 Increasing affordability to propel market 131
7.2.1.3 Low-slice CT scanners 132
7.2.1.3.1 Low costs and rising adoption in emerging economies to drive market 132
7.2.2 CONE-BEAM CT SCANNERS 133
7.2.2.1 Growing applications in dental & ENT scanning to drive market 133
7.3 ULTRASOUND SYSTEMS 134
7.3.1 ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY 134
7.3.2 2D ULTRASOUND SYSTEMS 135
7.3.2.1 Rise in demand for minimal invasive surgeries leading to increased use of 2D ultrasound 135
7.3.3 3D AND 4D ULTRASOUND 136
7.3.3.1 IMPROVED DIAGNOSIS WITH 3D ULTRASOUND TECHNOLOGY 136
7.3.4 DOPPLER ULTRASOUND 137
7.3.4.1 Growing application in cardiology and vascular to drive market growth 137
7.3.4.2 Contrast-enhanced ultrasound systems 138
7.3.4.2.1 Innovative product launches offering real-time monitoring capabilities to fuel market 138
7.3.5 ULTRASOUND SYSTEMS MARKET, BY PORTABILITY 139
7.3.5.1 Trolley/Cart-based ultrasound systems 140
7.3.5.1.1 Utilization in pediatric and abdominal applications to propel market 140
7.3.5.2 Compact/Handheld ultrasound systems 141
7.3.5.2.1 High portability and user-friendly features to drive market 141
7.4 X-RAY IMAGING SYSTEMS 142
7.4.1 X-RAY IMAGING SYSTEMS MARKET, BY TYPE 142
7.4.1.1 Digital X-ray imaging systems 143
7.4.1.2 Analog X-ray imaging systems 144
7.4.1.2.1 High risk of radiation exposure and limitations to impede market growth 144
7.4.2 X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY 145
7.4.2.1 Stationary X-ray imaging systems 146
7.4.2.1.1 Efficient configuration integration in diagnostic clinics to propel market 146
7.4.2.2 Portable X-ray imaging systems 146
7.4.2.2.1 Rising use in trauma care and emergency departments to boost adoption 146
7.5 MRI SYSTEMS 147
7.5.1 MRI SYSTEMS MARKET, BY ARCHITECTURE 148
7.5.1.1 Closed MRI systems 148
7.5.1.1.1 Reduced examination time and improved image quality to drive market 148
7.5.1.2 Open MRI systems 149
7.5.1.2.1 High patient comfort to boost adoption 149
7.5.2 MRI SYSTEMS MARKET, BY FIELD STRENGTH 150
7.5.2.1 High and very-high-field MRI systems 151
7.5.2.1.1 High safety & image resolution to drive market 151
7.5.2.2 Low-to-mid-field MRI systems 151
7.5.2.2.1 Technological limitations to restrain market 151
7.5.2.3 Ultra-high-field MRI systems 152
7.5.2.3.1 High utilization in musculoskeletal & neurological applications to support market growth 152
7.6 NUCLEAR IMAGING SYSTEMS 153
7.6.1 SPECT SYSTEMS 154
7.6.2 PET SYSTEMS 154
7.6.3 HYBRID SPECT SYSTEMS 155
7.6.3.1 Enhanced resolution to support market growth 155
7.7 MAMMOGRAPHY SYSTEMS 156
7.7.1 RISING AWARENESS ABOUT BREAST CANCER TO SUPPORT MARKET GROWTH 156
8 DIAGNOSTIC IMAGING MARKET, BY END USER 158
8.1 INTRODUCTION 159
8.2 HOSPITALS 159
8.2.1 INCREASED NUMBER OF MRI, PET, CT SCANS TO PROPEL DIAGNOSTIC IMAGING MARKET 159
8.3 DIAGNOSTIC IMAGING CENTERS 160
8.3.1 RISING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO FUEL MARKET 160
8.4 OTHER END USERS 161
9 DIAGNOSTIC IMAGING MARKET, BY REGION 163
9.1 INTRODUCTION 164
9.2 NORTH AMERICA 165
9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 165
9.2.2 US 171
9.2.2.1 High incidence of chronic diseases to drive market 171
9.2.3 CANADA 175
9.2.3.1 Rising cases of chronic disease to support market growth 175
9.3 ASIA PACIFIC 179
9.3.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 180
9.3.2 JAPAN 186
9.3.2.1 Presence of universal healthcare coverage to fuel market 186
9.3.3 CHINA 190
9.3.3.1 Government initiatives for establishment of hospitals to drive market 190
9.3.4 INDIA 194
9.3.4.1 Improvements in healthcare infrastructure and rising incidence of CVD to drive market 194
9.3.5 SOUTH KOREA 199
9.3.5.1 Growing access to advanced ultrasound systems to support market growth 199
9.3.6 AUSTRALIA 202
9.3.6.1 Increasing healthcare spending to propel market 202
9.3.7 REST OF ASIA PACIFIC 207
9.4 EUROPE 211
9.4.1 EUROPE: MACROECONOMIC OUTLOOK 211
9.4.2 GERMANY 216
9.4.2.1 High number of MRI units to drive the market 216
9.4.3 UK 220
9.4.3.1 Increasing investments in diagnostic imaging to drive market 220
9.4.4 ITALY 224
9.4.4.1 Established healthcare infrastructure to support market growth 224
9.4.5 SPAIN 228
9.4.5.1 Growing access to advanced cancer diagnostics to propel market 228
9.4.6 REST OF EUROPE 232
9.5 LATIN AMERICA 236
9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 236
9.5.2 BRAZIL 241
9.5.2.1 High export of medical devices to propel market 241
9.5.3 MEXICO 245
9.5.3.1 Rising R&D initiatives on oncology imaging to support market growth 245
9.5.4 REST OF LATIN AMERICA 249
9.6 MIDDLE EAST & AFRICA 252
9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 253
9.6.2 GCC COUNTRIES 258
9.6.2.1 Integration of AI to support market growth 258
9.6.3 REST OF MIDDLE EAST & AFRICA 262
9.6.3.1 Advancements in healthcare sector to support market growth 262
10 COMPETITIVE LANDSCAPE 266
10.1 INTRODUCTION 266
10.2 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN 266
10.3 REVENUE ANALYSIS, 2022–2024 269
10.4 MARKET SHARE ANALYSIS 270
10.5 RANKING OF KEY PLAYERS, 2024 272
10.6 COMPANY VALUATION AND FINANCIAL METRICS 272
10.7 BRAND/PRODUCT COMPARISON 274
10.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 275
10.8.1 STARS 275
10.8.2 PERVASIVE PLAYERS 275
10.8.3 EMERGING LEADERS 275
10.8.4 PARTICIPANTS 275
10.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 277
10.8.5.1 Company footprint 277
10.8.5.2 Modality footprint 278
10.8.5.3 Application footprint 279
10.8.5.4 End user footprint 280
10.8.5.5 Region footprint 281
10.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 282
10.9.1 PROGRESSIVE COMPANIES 282
10.9.2 RESPONSIVE COMPANIES 282
10.9.3 DYNAMIC COMPANIES 282
10.9.4 STARTING BLOCKS 282
10.9.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024 284
10.9.5.1 Detailed list of key startups/SMEs 284
10.9.5.2 Competitive benchmarking of key startups/SMEs 285
10.10 COMPETITIVE SCENARIO 286
10.10.1 PRODUCT LAUNCHES AND APPROVALS 286
10.10.2 DEALS 287
10.10.3 EXPANSIONS 289
11 COMPANY PROFILES 290
11.1 KEY PLAYERS 290
11.1.1 SIEMENS HEALTHINEERS 290
11.1.1.1 Business overview 290
11.1.1.2 Products offered 292
11.1.1.3 Recent developments 294
11.1.1.3.1 Product launches, upgrades, and approvals 294
11.1.1.3.2 Deals 296
11.1.1.3.3 Expansions 298
11.1.1.4 MnM view 298
11.1.1.4.1 Key strengths 298
11.1.1.4.2 Strategic choices 298
11.1.1.4.3 Weaknesses & competitive threats 298
11.1.2 GE HEALTHCARE 299
11.1.2.1 Business overview 299
11.1.2.2 Products offered 300
11.1.2.3 Recent developments 305
11.1.2.3.1 Product launches, upgrades, and approvals 305
11.1.2.3.2 Deals 306
11.1.2.3.3 Expansions 308
11.1.2.3.4 Other developments 309
11.1.2.4 MnM view 309
11.1.2.4.1 Key strengths 309
11.1.2.4.2 Strategic choices 309
11.1.2.4.3 Weaknesses and competitive threats 309
11.1.3 KONINKLIJKE PHILIPS N.V. 310
11.1.3.1 Business overview 310
11.1.3.2 Products offered 312
11.1.3.3 Recent developments 314
11.1.3.3.1 Product launches, upgrades, and approvals 314
11.1.3.3.2 Deals 314
11.1.3.3.3 Expansions 315
11.1.3.4 MnM view 316
11.1.3.4.1 Key strengths 316
11.1.3.4.2 Strategic choices 316
11.1.3.4.3 Weaknesses and competitive threats 316
11.1.4 FUJIFILM CORPORATION 317
11.1.4.1 Business overview 317
11.1.4.2 Products offered 319
11.1.4.3 Recent developments 321
11.1.4.3.1 Product launches, upgrades, and approvals 321
11.1.4.3.2 Deals 322
11.1.4.3.3 Expansions 323
11.1.4.4 MnM view 323
11.1.4.4.1 Right to win 323
11.1.4.4.2 Strategic choices 323
11.1.4.4.3 Weaknesses & competitive threats. 324
11.1.5 CANON 325
11.1.5.1 Business overview 325
11.1.5.2 Products offered 327
11.1.5.3 Recent developments 330
11.1.5.3.1 Product launches, upgrades, and approvals 330
11.1.5.3.2 Deals 331
11.1.5.3.3 Expansions 332
11.1.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 333
11.1.6.1 Business overview 333
11.1.6.2 Products offered 334
11.1.6.3 Recent developments 336
11.1.6.3.1 Product launches, upgrades, and approvals 336
11.1.6.3.2 Deals 337
11.1.7 ESAOTE S.P.A 338
11.1.7.1 Business overview 338
11.1.7.2 Products offered 338
11.1.7.3 Recent developments 340
11.1.7.3.1 Product launches, upgrades, and approvals 340
11.1.7.3.2 Deals 340
11.1.8 SAMSUNG HEALTHCARE 341
11.1.8.1 Business overview 341
11.1.8.2 Products offered 342
11.1.8.3 Recent developments 345
11.1.8.3.1 Product launches, upgrades, and approvals 345
11.1.8.3.2 Deals 346
11.1.8.3.3 Other developments 346
11.1.9 SHIMADZU CORPORATION 347
11.1.9.1 Business overview 347
11.1.9.2 Products offered 348
11.1.9.3 Recent developments 350
11.1.9.3.1 Product launches, upgrades, and approvals 350
11.1.9.3.2 Deals 350
11.1.10 CARESTREAM HEALTH 351
11.1.10.1 Business overview 351
11.1.10.2 Products offered 351
11.1.10.3 Recent developments 352
11.1.10.3.1 Product launches, upgrades, and approvals 352
11.1.10.3.2 Deals 353
11.1.11 PLANMED OY 354
11.1.11.1 Business overview 354
11.1.11.2 Products offered 355
11.1.12 HOLOGIC, INC. 356
11.1.12.1 Business overview 356
11.1.12.2 Products offered 357
11.1.12.3 Recent developments 358
11.1.12.3.1 Deals 358
11.1.13 AGFA-GEVAERT GROUP 359
11.1.13.1 Business overview 359
11.1.13.2 Products offered 360
11.1.14 CURVEBEAM AI, LTD. 362
11.1.14.1 Business overview 362
11.1.14.2 Products offered 362
11.1.14.3 Recent developments 363
11.1.14.3.1 Deals 363
11.1.15 UNITED IMAGING HEALTHCARE CO., LTD. 364
11.1.15.1 Business overview 364
11.1.15.2 Products offered 365
11.1.15.3 Recent developments 366
11.1.15.3.1 Product launches, upgrades, and approvals 366
11.1.15.3.2 Deals 367
11.1.15.3.3 Expansions 367
11.2 OTHER PLAYERS 368
11.2.1 ALLENGERS MEDICAL SYSTEMS LTD. 368
11.2.2 ANALOGIC CORPORATION 369
11.2.3 ASPECT IMAGING LTD. 370
11.2.4 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD. 371
11.2.5 CHISON MEDICAL TECHNOLOGIES CO., LTD. 372
11.2.6 KONICA MINOLTA, INC. 374
11.2.7 MEDGYN PRODUCTS, INC. 375
11.2.8 NEUSOFT MEDICAL SYSTEMS CO., LTD. 376
11.2.9 PROMED TECHNOLOGY CO., LTD. 378
11.2.10 CMR NAVISCAN 379
11.2.11 CLARIUS 380
11.2.12 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. 381
11.2.13 SHENZHEN ANKE HIGH-TECH., LTD. 382
11.2.14 STERNMED GMBH 383
11.2.15 TIME MEDICAL SYSTEMS 384
12 APPENDIX 385
12.1 DISCUSSION GUIDE 385
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 390
12.3 CUSTOMIZATION OPTIONS 392
12.4 RELATED REPORTS 392
12.5 AUTHOR DETAILS 393
LIST OF TABLES
TABLE 1 AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES 56
TABLE 2 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING SYSTEMS 58
TABLE 3 REGIONAL PRICING ANALYSIS OF KEY DIAGNOSTIC IMAGING MODALITIES,
2024 (USD) 65
TABLE 4 DIAGNOSTIC IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 69
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 71
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 73
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 73
TABLE 10 MEDICAL REIMBURSEMENT CODES FOR MRI PROCEDURES
IN THE US (AS OF 2025) 80
TABLE 11 MEDICAL REIMBURSEMENT CODES FOR CT IMAGING PROCEDURES
IN THE US (AS OF 2025) 82
TABLE 12 MEDICAL REIMBURSEMENT CODES FOR PET/CT IMAGING PROCEDURES
IN THE US (AS OF 2025) 83
TABLE 13 MEDICAL REIMBURSEMENT CODES FOR ULTRASOUND IMAGING PROCEDURES IN THE US (AS OF 2025) 83
TABLE 14 MEDICAL REIMBURSEMENT CODES FOR MAMMOGRAPHY IMAGING PROCEDURES IN THE US (AS OF 2025) 84
TABLE 15 MEDICAL REIMBURSEMENT CODES FOR RADIOLOGY PROCEDURES
IN THE US (AS OF 2025) 84
TABLE 16 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 101
TABLE 17 CASE STUDY 2: BETTER VISUALIZATION OF BREAST IMAGES IN WOMEN WITH DENSE BREAST TISSUE 101
TABLE 18 DIAGNOSTIC IMAGING MARKET: LIST OF MAJOR CONFERENCES AND EVENTS 102
TABLE 19 DIAGNOSTIC IMAGING MARKET: UNMET NEEDS 103
TABLE 20 US ADJUSTED RECIPROCAL TARIFF RATES (AS OF APRIL 13, 2025) 105
TABLE 21 DIAGNOSTIC IMAGING MARKET FOR X-RAY SYSTEMS, BY APPLICATION,
2023–2030 (USD MILLION) 108
TABLE 22 DIAGNOSTIC IMAGING MARKET FOR MRI SYSTEMS, BY APPLICATION,
2023–2030 (USD MILLION) 111
TABLE 23 DIAGNOSTIC IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY APPLICATION, 2023–2030 (USD MILLION) 115
TABLE 24 DIAGNOSTIC IMAGING MARKET FOR CT SCANNERS, BY APPLICATION,
2023–2030 (USD MILLION) 119
TABLE 25 DIAGNOSTIC IMAGING MARKET FOR NUCLEAR IMAGING SYSTEMS,
BY APPLICATION, 2023–2030 (USD MILLION) 122
TABLE 26 DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 128
TABLE 27 CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 129
TABLE 28 CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 129
TABLE 29 CONVENTIONAL CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 130
TABLE 30 CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130
TABLE 31 HIGH-SLICE CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 131
TABLE 32 MID-SLICE CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 132
TABLE 33 LOW-SLICE CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 133
TABLE 34 CBCT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 134
TABLE 35 ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 134
TABLE 36 ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 135
TABLE 37 2D ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 136
TABLE 38 3D AND 4D ULTRASOUND SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 137
TABLE 39 DOPPLER ULTRASOUND SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 138
TABLE 40 CONTRAST-ENHANCED ULTRASOUND SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 139
TABLE 41 ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 139
TABLE 42 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 140
TABLE 43 COMPACT/PORTABLE ULTRASOUND SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 141
TABLE 44 X-RAY IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 142
TABLE 45 X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 46 DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 144
TABLE 47 ANALOG X-RAY IMAGING SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 145
TABLE 48 X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 145
TABLE 49 STATIONARY X-RAY IMAGING SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 146
TABLE 50 PORTABLE X-RAY IMAGING SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 147
TABLE 51 MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 147
TABLE 52 MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 148
TABLE 53 CLOSED MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 149
TABLE 54 OPEN MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 150
TABLE 55 MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 150
TABLE 56 HIGH AND VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 151
TABLE 57 LOW-TO-MID-FIELD MRI SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 152
TABLE 58 ULTRA-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION,
2023–2030 (USD MILLION) 153
TABLE 59 NUCLEAR IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 153
TABLE 60 NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154
TABLE 61 SPECT SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 154
TABLE 62 PET SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 155
TABLE 63 HYBRID SPECT SYSTEM MARKET, BY REGION, 2023–2030 (USD MILLION) 156
TABLE 64 MAMMOGRAPHY SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 157
TABLE 65 DIAGNOSTIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 159
TABLE 66 DIAGNOSTIC IMAGING MARKET FOR HOSPITALS, BY REGION,
2023–2030 (USD MILLION) 160
TABLE 67 DIAGNOSTIC IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS,
BY REGION, 2023–2030 (USD MILLION) 161
TABLE 68 DIAGNOSTIC IMAGING MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 162
TABLE 69 DIAGNOSTIC IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 164
TABLE 70 NUMBER OF IMAGING TESTS IN UK 164
TABLE 71 NUMBER OF MRI UNITS PER COUNTRY 165
TABLE 72 NORTH AMERICA: MACROECONOMIC OUTLOOK 166
TABLE 73 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 167
TABLE 74 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 167
TABLE 75 NORTH AMERICA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 167
TABLE 76 NORTH AMERICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 168
TABLE 77 NORTH AMERICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 168
TABLE 78 NORTH AMERICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 168
TABLE 79 NORTH AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 169
TABLE 80 NORTH AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 169
TABLE 81 NORTH AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 169
TABLE 82 NORTH AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 170
TABLE 83 NORTH AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 170
TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 170
TABLE 85 US: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 172
TABLE 86 US: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 87 US: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 88 US: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 173
TABLE 89 US: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 173
TABLE 90 US: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 91 US: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 174
TABLE 92 US: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 174
TABLE 93 US: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 174
TABLE 94 US: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 95 CANADA: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 176
TABLE 96 CANADA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 97 CANADA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 177
TABLE 98 CANADA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 177
TABLE 99 CANADA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 177
TABLE 100 CANADA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 101 CANADA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 178
TABLE 102 CANADA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 178
TABLE 103 CANADA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 179
TABLE 104 CANADA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 179
TABLE 105 ASIA PACIFIC: MACROECONOMIC INDICATORS 180
TABLE 106 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 182
TABLE 107 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 182
TABLE 108 ASIA PACIFIC: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 109 ASIA PACIFIC: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 183
TABLE 110 ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 183
TABLE 111 ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 184
TABLE 112 ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 113 ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 184
TABLE 114 ASIA PACIFIC: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 185
TABLE 115 ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 185
TABLE 116 ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 185
TABLE 117 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 186
TABLE 118 JAPAN: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 187
TABLE 119 JAPAN: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 120 JAPAN: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 187
TABLE 121 JAPAN: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 188
TABLE 122 JAPAN: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 123 JAPAN: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 188
TABLE 124 JAPAN: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 189
TABLE 125 JAPAN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 189
TABLE 126 JAPAN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 189
TABLE 127 CHINA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 191
TABLE 128 CHINA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191
TABLE 129 CHINA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 192
TABLE 130 CHINA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 192
TABLE 131 CHINA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 192
TABLE 132 CHINA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 133 CHINA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 193
TABLE 134 CHINA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 193
TABLE 135 CHINA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 194
TABLE 136 CHINA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 137 INDIA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 195
TABLE 138 INDIA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 139 INDIA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 140 INDIA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 196
TABLE 141 INDIA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 197
TABLE 142 INDIA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197
TABLE 143 INDIA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 197
TABLE 144 INDIA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 198
TABLE 145 INDIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 198
TABLE 146 INDIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 198
TABLE 147 SOUTH KOREA: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 199
TABLE 148 SOUTH KOREA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200
TABLE 149 SOUTH KOREA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 200
TABLE 150 SOUTH KOREA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 200
TABLE 151 SOUTH KOREA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 201
TABLE 152 SOUTH KOREA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 201
TABLE 153 SOUTH KOREA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 201
TABLE 154 SOUTH KOREA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 202
TABLE 155 SOUTH KOREA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 202
TABLE 156 AUSTRALIA: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 203
TABLE 157 AUSTRALIA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 158 AUSTRALIA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 204
TABLE 159 AUSTRALIA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 204
TABLE 160 AUSTRALIA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 205
TABLE 161 AUSTRALIA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 162 AUSTRALIA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 205
TABLE 163 AUSTRALIA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 206
TABLE 164 AUSTRALIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 206
TABLE 165 AUSTRALIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 206
TABLE 166 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 207
TABLE 167 REST OF ASIA PACIFIC: CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 168 REST OF ASIA PACIFIC: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 208
TABLE 169 REST OF ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 208
TABLE 170 REST OF ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 209
TABLE 171 REST OF ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 209
TABLE 172 REST OF ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 209
TABLE 173 REST OF ASIA PACIFIC: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 210
TABLE 174 REST OF ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 210
TABLE 175 REST OF ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 176 EUROPE: MACROECONOMIC OUTLOOK 212
TABLE 177 EUROPE: DIAGNOSTIC IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 212
TABLE 178 EUROPE: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212
TABLE 179 EUROPE: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 213
TABLE 180 EUROPE: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 213
TABLE 181 EUROPE: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 213
TABLE 182 EUROPE: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 183 EUROPE: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 214
TABLE 184 EUROPE: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 214
TABLE 185 EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 215
TABLE 186 EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 215
TABLE 187 EUROPE: DIAGNOSTIC IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 215
TABLE 188 GERMANY: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 216
TABLE 189 GERMANY: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 190 GERMANY: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 217
TABLE 191 GERMANY: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 217
TABLE 192 GERMANY: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 218
TABLE 193 GERMANY: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 218
TABLE 194 GERMANY: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 218
TABLE 195 GERMANY: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 219
TABLE 196 GERMANY: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 219
TABLE 197 GERMANY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 219
TABLE 198 UK: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 221
TABLE 199 UK: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 200 UK: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221
TABLE 201 UK: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 222
TABLE 202 UK: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 222
TABLE 203 UK: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222
TABLE 204 UK: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 223
TABLE 205 UK: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 223
TABLE 206 UK: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 223
TABLE 207 UK: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224
TABLE 208 ITALY: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 225
TABLE 209 ITALY: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225
TABLE 210 ITALY: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 225
TABLE 211 ITALY: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 226
TABLE 212 ITALY: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 226
TABLE 213 ITALY: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 214 ITALY: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 227
TABLE 215 ITALY: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 227
TABLE 216 ITALY: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 227
TABLE 217 ITALY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 228
TABLE 218 SPAIN: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 229
TABLE 219 SPAIN: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229
TABLE 220 SPAIN: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 229
TABLE 221 SPAIN: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 230
TABLE 222 SPAIN: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 230
TABLE 223 SPAIN: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 224 SPAIN: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 231
TABLE 225 SPAIN: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 231
TABLE 226 SPAIN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 231
TABLE 227 SPAIN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 232
TABLE 228 REST OF EUROPE: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 232
TABLE 229 REST OF EUROPE: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 230 REST OF EUROPE: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 233
TABLE 231 REST OF EUROPE: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 233
TABLE 232 REST OF EUROPE: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 234
TABLE 233 REST OF EUROPE: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 234
TABLE 234 REST OF EUROPE: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 234
TABLE 235 REST OF EUROPE: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 235
TABLE 236 REST OF EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 235
TABLE 237 REST OF EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 235
TABLE 238 LATIN AMERICA: MACROECONOMIC OUTLOOK 237
TABLE 239 LATIN AMERICA: DIAGNOSTIC IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 237
TABLE 240 LATIN AMERICA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 241 LATIN AMERICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 238
TABLE 242 LATIN AMERICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 238
TABLE 243 LATIN AMERICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 238
TABLE 244 LATIN AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 239
TABLE 245 LATIN AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 239
TABLE 246 LATIN AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 239
TABLE 247 LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 240
TABLE 248 LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 240
TABLE 249 LATIN AMERICA: DIAGNOSTIC IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 240
TABLE 250 BRAZIL: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 241
TABLE 251 BRAZIL: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242
TABLE 252 BRAZIL: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 253 BRAZIL: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 242
TABLE 254 BRAZIL: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 243
TABLE 255 BRAZIL: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243
TABLE 256 BRAZIL: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 243
TABLE 257 BRAZIL: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 244
TABLE 258 BRAZIL: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 244
TABLE 259 BRAZIL: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 244
TABLE 260 MEXICO: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 245
TABLE 261 MEXICO: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 246
TABLE 262 MEXICO: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 246
TABLE 263 MEXICO: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 246
TABLE 264 MEXICO: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 247
TABLE 265 MEXICO: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 266 MEXICO: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 247
TABLE 267 MEXICO: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 248
TABLE 268 MEXICO: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 248
TABLE 269 MEXICO: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 270 REST OF LATIN AMERICA: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 249
TABLE 271 REST OF LATIN AMERICA: CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 272 REST OF LATIN AMERICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 273 REST OF LATIN AMERICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 250
TABLE 274 REST OF LATIN AMERICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 250
TABLE 275 REST OF LATIN AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 251
TABLE 276 REST OF LATIN AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 251
TABLE 277 REST OF LATIN AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 251
TABLE 278 REST OF LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 252
TABLE 279 REST OF LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 252
TABLE 280 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 253
TABLE 281 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 254
TABLE 282 MIDDLE EAST & AFRICA: CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 254
TABLE 283 MIDDLE EAST & AFRICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 255
TABLE 284 MIDDLE EAST & AFRICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 255
TABLE 285 MIDDLE EAST & AFRICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 255
TABLE 286 MIDDLE EAST & AFRICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 256
TABLE 287 MIDDLE EAST & AFRICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 256
TABLE 288 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 256
TABLE 289 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 257
TABLE 290 MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 257
TABLE 291 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 257
TABLE 292 GCC COUNTRIES: DIAGNOSTIC IMAGING MARKET, BY MODALITY,
2023–2030 (USD MILLION) 258
TABLE 293 GCC COUNTRIES: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 294 GCC COUNTRIES: CONVENTIONAL CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 259
TABLE 295 GCC COUNTRIES: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 259
TABLE 296 GCC COUNTRIES: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 260
TABLE 297 GCC COUNTRIES: X-RAY IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 260
TABLE 298 GCC COUNTRIES: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY,
2023–2030 (USD MILLION) 260
TABLE 299 GCC COUNTRIES: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2023–2030 (USD MILLION) 261
TABLE 300 GCC COUNTRIES: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2023–2030 (USD MILLION) 261
TABLE 301 GCC COUNTRIES: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 302 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING MARKET,
BY MODALITY, 2023–2030 (USD MILLION) 262
TABLE 303 REST OF MIDDLE EAST & AFRICA: CT SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 263
TABLE 304 REST OF MIDDLE EAST & AFRICA: CONVENTIONAL CT SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 263
TABLE 305 REST OF MIDDLE EAST & AFRICA: ULTRASOUND SYSTEMS MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 263
TABLE 306 REST OF MIDDLE EAST & AFRICA: ULTRASOUND SYSTEMS MARKET,
BY PORTABILITY, 2023–2030 (USD MILLION) 264
TABLE 307 REST OF MIDDLE EAST & AFRICA: X-RAY IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 308 REST OF MIDDLE EAST & AFRICA: X-RAY IMAGING SYSTEMS MARKET,
BY PORTABILITY, 2023–2030 (USD MILLION) 264
TABLE 309 REST OF MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 265
TABLE 310 REST OF MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 265
TABLE 311 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 312 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
DIAGNOSTIC IMAGING MARKET, 2022–2025 266
TABLE 313 DIAGNOSTIC IMAGING MARKET: DEGREE OF COMPETITION 270
TABLE 314 DIAGNOSTIC IMAGING MARKET: MODALITY FOOTPRINT 278
TABLE 315 DIAGNOSTIC IMAGING MARKET: APPLICATION FOOTPRINT 279
TABLE 316 DIAGNOSTIC IMAGING MARKET: END USER FOOTPRINT 280
TABLE 317 DIAGNOSTIC IMAGING MARKET: REGION FOOTPRINT 281
TABLE 318 DIAGNOSTIC IMAGING MARKET: KEY STARTUPS/SMES 284
TABLE 319 DIAGNOSTIC IMAGING MARKET: COMPETITIVE
BENCHMARKING OF KEY STARTUPS/SMES 285
TABLE 320 DIAGNOSTIC IMAGING MARKET: PRODUCT LAUNCHES, UPGRADES,
AND APPROVALS, JANUARY 2022–JUNE 2025 287
TABLE 321 DIAGNOSTIC IMAGING MARKET: DEALS, JANUARY 2022–JUNE 2025 288
TABLE 322 DIAGNOSTIC IMAGING MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 289
TABLE 323 SIEMENS HEALTHINEERS: COMPANY OVERVIEW 290
TABLE 324 SIEMENS HEALTHINEERS: PRODUCTS OFFERED 292
TABLE 325 SIEMENS HEALTHINEERS: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 294
TABLE 326 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–JUNE 2025 296
TABLE 327 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022–JUNE 2025 298
TABLE 328 GE HEALTHCARE: COMPANY OVERVIEW 299
TABLE 329 GE HEALTHCARE: PRODUCTS OFFERED 300
TABLE 330 GE HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND
APPROVALS, JANUARY 2022–JUNE 2025 305
TABLE 331 GE HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025 306
TABLE 332 GE HEALTHCARE: EXPANSIONS, JANUARY 2022–JUNE 2025 308
TABLE 333 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 309
TABLE 334 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 310
TABLE 335 KONIKLIJKE PHILIPS: PRODUCTS OFFERED 312
TABLE 336 KONINKLIJKE PHILIPS N.V. PRODUCT LAUNCHES, UPGRADES, AND APPROVALS JANUARY 2022–JUNE 2025 314
TABLE 337 PHILIPS HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025 314
TABLE 338 PHILIPS HEALTHCARE.: EXPANSIONS, JANUARY 2022–JUNE 2025 315
TABLE 339 FUJIFILM CORPORATION: COMPANY OVERVIEW 317
TABLE 340 FUJIFLIM CORPORATION: PRODUCTS OFFERED 319
TABLE 341 FUJIFLIM CORPORATION: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 321
TABLE 342 FUJIFLIM CORPORATION: DEALS, JANUARY 2022–JUNE 2025 322
TABLE 343 FUJIFLIM CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2025 323
TABLE 344 CANON : COMPANY OVERVIEW 325
TABLE 345 CANON: PRODUCTS OFFERED 327
TABLE 346 CANON MEDICAL SYSTEM: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 330
TABLE 347 CANON MEDICAL SYSTEM: DEALS, JANUARY 2022–JUNE 2025 331
TABLE 348 CANON MEDICAL SYSTEM: EXPANSIONS, JANUARY 2022–JUNE 2025 332
TABLE 349 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 333
TABLE 350 SHEZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: PRODUCTS OFFERED 334
TABLE 351 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 336
TABLE 352 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: DEALS,
JANUARY 2022–JUNE 2025 337
TABLE 353 ESAOTE SPA: BUSINESS OVERVIEW 338
TABLE 354 ESAOTE SPA: PRODUCTS OFFERED 338
TABLE 355 ESAOTE SPA: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS,
JANUARY 2022–JUNE 2025 340
TABLE 356 ESAOTE SPA: DEALS, JANUARY 2022–JUNE 2025 340
TABLE 357 SAMSUNG HEALTHCARE: COMPANY OVERVIEW 341
TABLE 358 SAMSUNG HEALTHCARE: PRODUCTS OFFERED 342
TABLE 359 SAMSUNG HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 345
TABLE 360 SAMSUNG HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025 346
TABLE 361 SAMSUNG HEALTHCARE.: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 346
TABLE 362 SHIMADZU CORPORATION: BUSINESS OVERVIEW 347
TABLE 363 SHIMADZU CORPORATION: PRODUCTS OFFERED 348
TABLE 364 SHIMADZU CORPORATION: PRODUCT LAUNCHES, UPGRADES,
AND APPROVALS, JANUARY 2022–JUNE 2025 350
TABLE 365 SHIMADZU CORPORATION: DEALS, JANUARY 2022–JUNE 2025 350
TABLE 366 CARESTREAM HEALTH: BUSINESS OVERVIEW 351
TABLE 367 CARESTREAM HEALTH: PRODUCTS OFFERED 351
TABLE 368 CARESTREAM HEALTH: PRODUCT APPROVALS, UPGRADES, AND LAUNCHES, JANUARY 2022–JUNE 2025 352
TABLE 369 CARESTREAM HEALTH: DEALS, JANUARY 2022–JUNE 2025 353
TABLE 370 PLANMED OY: BUSINESS OVERVIEW 354
TABLE 371 PLANMED OY: PRODUCTS OFFERED 355
TABLE 372 HOLOGIC, INC.: COMPANY OVERVIEW 356
TABLE 373 HOLOGIC, INC.: PRODUCTS OFFERED 357
TABLE 374 HOLOGIC, INC.: DEALS, JANUARY 2022–JUNE 2025 358
TABLE 375 AGFA-GEVAERT GROUP: BUSINESS OVERVIEW 359
TABLE 376 AGFA-GEVAERTA GROUP: PRODUCTS OFFERED 360
TABLE 377 CURVEBEAM AI, LTD.: BUSINESS OVERVIEW 362
TABLE 378 CURVEBEAM AI: PRODUCTS OFFERED 362
TABLE 379 CURVEBEAM AI: DEALS, JANUARY 2022–JUNE 2025 363
TABLE 380 UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW 364
TABLE 381 UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCTS OFFERED 365
TABLE 382 UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 366
TABLE 383 UNITED IMAGING HEALTHCARE CO., LTD.: DEALS, JANUARY 2022–JUNE 2025 367
TABLE 384 UNITED IMAGING HEALTHCARE CO., LTD.: EXPANSIONS,
JANUARY 2022–JUNE 2025 367
TABLE 385 ALLENGERS MEDICAL SYSTEMS LTD: COMPANY OVERVIEW 368
TABLE 386 ANALOGIC CORPORATION: COMPANY OVERVIEW 369
TABLE 387 ASPECT IMAGING LTD: COMPANY OVERVIEW 370
TABLE 388 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 371
TABLE 389 CHISON MEDICAL TECHNOLOGIES CO.,LTD.: COMPANY OVERVIEW 372
TABLE 390 KONICA MINOLTA, INC.: COMPANY OVERVIEW 374
TABLE 391 MEDGYN PRODUCTS, INC.: COMPANY OVERVIEW 375
TABLE 392 NEUSOFT MEDICAL SYSTEMS CO., LTD: COMPANY OVERVIEW 376
TABLE 393 PROMED TECHNOLOGY CO., LTD: COMPANY OVERVIEW 378
TABLE 394 CMR NAVISCAN: COMPANY OVERVIEW 379
TABLE 395 CLARIUS: COMPANY OVERVIEW 380
TABLE 396 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD: COMPANY OVERVIEW 381
TABLE 397 SHENZHEN ANKE HIGH-TECH., LTD: COMPANY OVERVIEW 382
TABLE 398 STERNMED GMBH: COMPANY OVERVIEW 383
TABLE 399 TIME MEDICAL SYSTEMS: COMPANY OVERVIEW 384
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 37
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 41
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 42
FIGURE 5 MARKET SIZE ESTIMATION FOR DIAGNOSTIC IMAGING MARKET:
APPROACH 1 (COMPANY REVENUE ESTIMATION) 43
FIGURE 6 DIAGNOSTIC IMAGING MARKET: BOTTOM-UP APPROACH
FOR MARKET SIZE ESTIMATION 44
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
FIGURE 8 DATA TRIANGULATION METHODOLOGY 46
FIGURE 9 DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION) 49
FIGURE 10 DIAGNOSTIC IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 50
FIGURE 11 DIAGNOSTIC IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50
FIGURE 12 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 52
FIGURE 13 HOSPITALS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025 53
FIGURE 14 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 54
FIGURE 15 DIAGNOSTIC IMAGING MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 55
FIGURE 16 VALUE CHAIN ANALYSIS 67
FIGURE 17 SUPPLY CHAIN ANALYSIS 69
FIGURE 18 DIAGNOSTICS IMAGING MARKET: TRENDS/DISRUPTIONS IMPACTING
CUSTOMER BUSINESS 76
FIGURE 19 DIAGNOSTICS IMAGING MARKET: IMPORT SCENARIO FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212) 87
FIGURE 20 DIAGNOSTICS IMAGING MARKET: EXPORT SCENARIO FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212) 88
FIGURE 21 DIAGNOSTICS IMAGING MARKET: IMPORT SCENARIO FOR
ULTRASOUND SYSTEMS (HS CODE 901812) 89
FIGURE 22 DIAGNOSTICS IMAGING MARKET: EXPORT SCENARIO FOR
ULTRASOUND SYSTEMS (HS CODE 901812) 90
FIGURE 23 DIAGNOSTICS IMAGING MARKET: IMPORT SCENARIO
FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813) 91
FIGURE 24 DIAGNOSTICS IMAGING MARKET: EXPORT SCENARIO
FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813) 92
FIGURE 25 DIAGNOSTICS IMAGING MARKET: IMPORT SCENARIO
FOR X-RAY SYSTEMS (HS CODE 902214) 93
FIGURE 26 DIAGNOSTICS IMAGING MARKET: EXPORT SCENARIO
FOR X-RAY SYSTEMS (HS CODE 902214) 94
FIGURE 27 TOP 10 PATENT APPLICANTS FOR CT SCANNERS (JANUARY 2015–AUGUST 2025) 95
FIGURE 28 TOP 10 PATENT APPLICANTS FOR MRI SYSTEMS (JANUARY 2015–AUGUST 2025) 96
FIGURE 29 TOP 10 PATENT APPLICANTS FOR ULTRASOUND IMAGING SYSTEMS
(JANUARY 2015–DECEMBER 2025) 97
FIGURE 30 TOP 10 PATENT APPLICANTS FOR MAMMOGRAPHY SYSTEMS
(JANUARY 2015–DECEMBER 2025) 98
FIGURE 31 TOP 10 PATENT APPLICANTS FOR X-RAY IMAGING SYSTEMS
(JANUARY 2015–DECEMBER 2025) 99
FIGURE 32 TOP 10 PATENT APPLICANTS FOR NUCLEAR IMAGING SYSTEMS
(JANUARY 2015–DECEMBER 2025) 100
FIGURE 33 COMPUTED RADIOGRAPHY VS. DIRECT RADIOGRAPHY 143
FIGURE 34 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET SNAPSHOT 166
FIGURE 35 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET SNAPSHOT 181
FIGURE 36 REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2022–2024 (USD MILLION) 269
FIGURE 37 MARKET SHARE OF KEY PLAYERS, 2024 270
FIGURE 38 RANKING OF KEY PLAYERS, 2024 272
FIGURE 39 EV/EBITDA OF TOP THREE PLAYERS, 2025 272
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF TOP THREE VENDORS, 2025 273
FIGURE 41 BRAND/PRODUCT COMPARISON 274
FIGURE 42 DIAGNOSTIC IMAGING MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 276
FIGURE 43 DIAGNOSTIC IMAGING MARKET: COMPANY FOOTPRINT 277
FIGURE 44 DIAGNOSTIC IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 283
FIGURE 45 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2024) 291
FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 300
FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 311
FIGURE 48 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024) 318
FIGURE 49 CANON INC.: COMPANY SNAPSHOT (2024) 326
FIGURE 50 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT (2022) 333
FIGURE 51 SAMSUNG HEALTHCARE: COMPANY SNAPSHOT (2024) 342
FIGURE 52 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 348
FIGURE 53 HOLOGIC, INC.: COMPANY SNAPSHOT (2024) 357
FIGURE 54 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2024) 360
FIGURE 55 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2024) 364
MarketsandMarkets(マーケッツアンドマーケッツ)は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間~12時間以内(営業日基準)にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連会社除く)5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100%持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内(営業日基準)
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11